Earnings History Data for Inovio Pharmaceuticals, Inc. (INO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-03-2024 AH INO Inovio Pharmaceuticals, Inc. 217.25 N/A -1.58 -2.52 Inovio Pharmaceuticals GAAP EPS of -$1.10 beats by $0.14, revenue of $103M
[3/6/2024 4:12 PM]
9.04 -0.83 
(-8.41%)
9.65 -0.22 
(-2.23%)
3.89 - 14.88 809,916 470,000 4,609
09-11-2023 AH INO Inovio Pharmaceuticals, Inc. 102.14 -0.09 -0.13 -0.15 Inovio Pharmaceuticals Non-GAAP EPS of -$0.09 beats by $0.04, revenue of $0.39M beats by $0.27M
[11/9/2023 4:09 PM]
0.3461 -0.02 
(-4.42%)
0.36 0.0 
(-0.72%)
0.32 - 2.61 3,827,059 2,260,000 91,084
09-08-2023 AH INO Inovio Pharmaceuticals, Inc. 111.66 -0.13 -0.14 -0.46 Inovio Pharmaceuticals GAAP EPS of -$0.13 beats by $0.01, revenue of $0.23M misses by $0.03M
[8/9/2023 4:07 PM]
0.4491 0.05 
(11.19%)
0.41 0.01 
(1.56%)
0.38 - 2.82 4,440,480 2,660,000 28,164
10-05-2023 AH 4:05 PM ET
(May 10)
INO Inovio Pharmaceuticals, Inc. 218.42 -0.16 -0.14 -0.36 Inovio Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $0.11M misses by $0.17M
[5/10/2023 4:09 PM]
0.8007 -0.01 
(-1.10%)
0.80 -0.01 
(-1.19%)
0.69 - 2.82 3,835,678 4,390,000 22,939
01-03-2023 AH 4:05 PM ET
(Mar 1)
INO Inovio Pharmaceuticals, Inc. 349.28 -0.21 -0.16 -0.50 Inovio Pharmaceuticals GAAP EPS of -$1.17 misses by $0.06, revenue of $10.26M misses by $0.29M
[3/1/2023 4:08 PM]
1.31 0.07 
(6.05%)
1.28 0.04 
(3.23%)
1.19 - 4.00 2,925,226 3,900,000 36,127
08-11-2022 AH 4:05 PM ET
(Nov 8)
INO Inovio Pharmaceuticals, Inc. 533.72 -0.15 -0.29 -0.29 Inovio Pharmaceuticals GAAP EPS of -$0.15 beats by $0.15, revenue of $9.15M
[11/8/2022 4:08 PM]
2.19 0.05 
(2.57%)
2.12 -0.02 
(-0.93%)
1.38 - 7.77 7,598,811 6,640,000 16,619
09-08-2022 AH 4:05 PM ET
(Aug 9)
INO Inovio Pharmaceuticals, Inc. 437.47 -0.46 -0.30 -0.39 Inovio Pharmaceuticals GAAP EPS of -$0.46 misses by $0.15, revenue of $0.78M beats by $0.26M
[8/9/2022 4:12 PM]
2.59 0.49 
(23.33%)
2.21 0.11 
(5.24%)
1.38 - 9.96 10,004,481 5,790,000 47,446
10-05-2022 AH 4:05 PM ET
(May 10)
INO Inovio Pharmaceuticals, Inc. 589.93 -0.36 -0.28 -0.27 Inovio Pharmaceuticals Non-GAAP EPS of -$0.36, revenue of $0.2M
[5/10/2022 4:10 PM]
1.80 -0.68 
(-27.51%)
2.03 -0.46 
(-18.48%)
1.60 - 10.33 16,142,344 4,150,000 189,943
01-03-2022 AH 4:05 PM ET
(Mar 1)
INO Inovio Pharmaceuticals, Inc. 677.44 -0.50 -0.33 -0.14 Inovio Pharmaceuticals GAAP EPS of -$1.45 misses by $0.19, revenue of $1.77M beats by $0.31M
[3/1/2022 4:11 PM]
3.04 -0.20 
(-6.33%)
2.99 -0.25 
(-7.72%)
2.76 - 11.00 6,495,794 3,800,000 121,030
09-11-2021 AH 4:05 PM ET
(Nov 9)
INO Inovio Pharmaceuticals, Inc. 1,490 -0.29 -0.33 -0.22 Inovio Pharmaceuticals EPS beats by $0.04, misses on revenue
[11/9/2021 4:11 PM]
7.13 0.08 
(1.13%)
7.13 0.08 
(1.13%)
5.81 - 19.00 7,548,552 4,110,000 61,191
09-08-2021 AH 4:05 PM ET
(Aug 9)
INO Inovio Pharmaceuticals, Inc. 1,930 -0.39 -0.25 -0.23 Inovio Pharmaceuticals EPS misses by $0.14, misses on revenue
[8/9/2021 4:07 PM]
8.57 -1.03 
(-10.73%)
9.24 -0.36 
(-3.75%)
5.81 - 19.66 10,539,791 3,970,000 110,834
10-05-2021 AH 4:15 PM ET
(May 10)
INO Inovio Pharmaceuticals, Inc. 1,360 -0.27 -0.18 -0.26 Inovio Pharmaceuticals EPS misses by $0.08, misses on revenue
[5/10/2021 4:07 PM]
6.49 -0.18 
(-2.77%)
5.89 -0.78 
(-11.69%)
5.81 - 33.79 8,743,472 7,830,000 486,738
01-03-2021 AH 4:05 PM ET
(Mar 1)
INO Inovio Pharmaceuticals, Inc. 2,350 -0.14 -0.22 -0.32 Inovio Pharmaceuticals EPS beats by $0.08, beats on revenue
[3/1/2021 4:17 PM]
10.04 -1.56 
(-13.49%)
11.00 -0.60 
(-5.17%)
3.83 - 33.79 19,775,457 13,309,840 482,100
09-11-2020 AH 4:05 PM ET
(Nov 9)
INO Inovio Pharmaceuticals, Inc. 1,810 -0.22 -0.18 -0.27 Inovio Pharmaceuticals EPS beats by $0.30, misses on revenue
[11/9/2020 4:06 PM]
11.53 3.03 
(35.65%)
8.99 0.49 
(5.76%)
2.19 - 33.79 34,105,635 7,636,011 183,457
10-08-2020 AH 4:05 PM ET
(Aug 10)
INO Inovio Pharmaceuticals, Inc. 3,210 -0.23 -0.18 -0.30 Inovio Pharmaceuticals EPS misses by $0.66, misses on revenue
[8/10/2020 4:10 PM]
15.03 -3.96 
(-20.85%)
16.49 -2.50 
(-13.16%)
1.92 - 33.79 30,351,556 19,297,204 2,035,589